[1]
Pandey, J.R.C., Vyas, G.N., Dutta, E.H., Shah, S.K. and Patel, H.J. 2026. A comprehensive review of biomarker-based therapies for hormone receptor-positive and HER2-low breast cancer: clinical pharmacists’ implications. International Journal of Basic & Clinical Pharmacology. 15, 3 (Apr. 2026), 589–593. DOI:https://doi.org/10.18203/2319-2003.ijbcp20261129.